Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

AVN

Avanir (AVN)

12% Strides Linked TO Apple, Inc.
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:AVN
FechaHoraFuenteTítuloSímboloCompañía
29/08/200715:45PR Newswire (US)American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc.AMEX:AVN
01/02/200607:00PR Newswire (US)Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of DirectorsAMEX:AVN
17/01/200615:15Business WireAVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker SymbolAMEX:AVN12% Strides Linked TO Apple, Inc.
11/01/200607:35Business WireAVANIR Licenses Docosanol 10% Cream in JapanAMEX:AVN12% Strides Linked TO Apple, Inc.
11/01/200607:30Business WireAVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical AffairsAMEX:AVN12% Strides Linked TO Apple, Inc.
06/01/200606:30Business WireAVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock SplitAMEX:AVN12% Strides Linked TO Apple, Inc.
04/01/200615:00Business WireAVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference WebcastAMEX:AVN12% Strides Linked TO Apple, Inc.
03/01/200607:30Business WirePhase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million MilestoneAMEX:AVN12% Strides Linked TO Apple, Inc.
23/11/200515:10Business WireAVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference WebcastAMEX:AVN12% Strides Linked TO Apple, Inc.
14/11/200508:00Business WireAVANIR Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of DirectorsAMEX:AVN12% Strides Linked TO Apple, Inc.
02/11/200515:56Business WireAVANIR Pharmaceuticals Invites Investors to the CIBC and the Rodman & Renshaw Healthcare Conference WebcastsAMEX:AVN12% Strides Linked TO Apple, Inc.
18/10/200513:14Business WireAVANIR Announces $16 Million Common Stock OfferingAMEX:AVN12% Strides Linked TO Apple, Inc.
27/09/200508:00Business WireAVANIR Pharmaceuticals Appoints Craig Wheeler to Board Of DirectorsAMEX:AVN12% Strides Linked TO Apple, Inc.
22/09/200507:00Business WireFurther Update on AVANIR's Neurodex(TM) New Drug ApplicationAMEX:AVN12% Strides Linked TO Apple, Inc.
16/09/200515:55Business WireAVANIR Pharmaceuticals Invites Investors to the Bank of America and the UBS Global Life Sciences Conference WebcastsAMEX:AVN12% Strides Linked TO Apple, Inc.
31/08/200518:56Business WireUpdate on AVANIR's Neurodex(TM) New Drug ApplicationAMEX:AVN12% Strides Linked TO Apple, Inc.
15/08/200508:00Business WireAVANIR Pharmaceuticals Reports Third Quarter Fiscal 2005 Financial ResultsAMEX:AVN12% Strides Linked TO Apple, Inc.
11/07/200513:26Business WireAVANIR Announces Corporate Update Conference CallAMEX:AVN12% Strides Linked TO Apple, Inc.
11/07/200508:15Business WireAstraZeneca and AVANIR Announce Global Alliance to Discover and Develop Novel Reverse Cholesterol Transport Enhancing CompoundsAMEX:AVN12% Strides Linked TO Apple, Inc.
06/07/200508:00Business WireAVANIR Strengthens Its Sales and Marketing TeamAMEX:AVN12% Strides Linked TO Apple, Inc.
05/07/200508:00Business WireAVANIR Pharmaceuticals Added to 2005 Russell IndicesAMEX:AVN12% Strides Linked TO Apple, Inc.
30/06/200506:30Business WireAVANIR Submits NDA for Neurodex(TM)AMEX:AVN12% Strides Linked TO Apple, Inc.
23/06/200508:00Business WireAVANIR Initiates Phase III Clinical Trial of Neurodex for the Treatment of Diabetic Neuropathic PainAMEX:AVN12% Strides Linked TO Apple, Inc.
20/06/200517:04Business WireAVANIR Pharmaceuticals Files Shelf Registration StatementAMEX:AVN12% Strides Linked TO Apple, Inc.
06/06/200512:11Business WireAVANIR's Investigational Anthrax Antibody Effective in Recognized Animal Model; UTMB Scientists Present Data at ASM MeetingAMEX:AVN12% Strides Linked TO Apple, Inc.
03/06/200513:31Business WireAVANIR Invites Investors to Webcast of Pacific Growth Equities Life Sciences Growth Conference PresentationAMEX:AVN12% Strides Linked TO Apple, Inc.
31/05/200512:33Business WireAVANIR Amends Terms of Existing Warrant; Warrant to Expire if Not Exercised by July 26, 2005AMEX:AVN12% Strides Linked TO Apple, Inc.
13/05/200507:30Business WireWebcast Alert: AVANIR Pharmaceuticals Announces Its Second Quarter 2005 Conference Call WebcastAMEX:AVN12% Strides Linked TO Apple, Inc.
10/05/200516:54Business WireAVANIR Pharmaceuticals Invites Investors to Its Second Fiscal Quarter 2005 Conference Call on May 16, 2005AMEX:AVN12% Strides Linked TO Apple, Inc.
29/12/200304:00PR Newswire (US)New Research Gives Hope to Stroke Survivors with Uncontrolled EmotionsAMEX:AVN12% Strides Linked TO Apple, Inc.
 Showing the most relevant articles for your search:AMEX:AVN